UniProtKB/Swiss-Prot Q14839: Variant p.Val1608Ile

Chromodomain-helicase-DNA-binding protein 4
Gene: CHD4
Feedback?

Variant information Variant position:

1608 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

US The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Valine (V) to Isoleucine (I) at position 1608 (V1608I, p.Val1608Ile). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Similar physico-chemical property. Both residues are medium size and hydrophobic. The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

3 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Variant description:

In SIHIWES; uncertain significance. Any additional useful information about the variant.
Other resources:

Links to websites of interest for the variant.

Variant rs201992075 [ dbSNP | Ensembl ]

Sequence information Variant position:

1608 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

1912 The length of the canonical sequence.
Location on the sequence:

PETAIECTQAPAPASEDEKV V VEPPEGEEKVEKAEVKERTE The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         PETAIECTQAPAP----------ASEDEKVVVEPPEGEEKVEKAEVKERTE

Mouse                         PEATVECAQPPAPAPATAPATATAPEDDKAPAEPPEGEEKV

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 1912	Chromodomain-helicase-DNA-binding protein 4
Region	1577 – 1912	Required for interaction with PCNT
Region	1594 – 1644	Disordered
Compositional bias	1606 – 1644	Basic and acidic residues
Modified residue	1602 – 1602	Phosphoserine
Cross	1606 – 1606	Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)
Cross	1617 – 1617	Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)

Literature citations
Distinct genetic architectures for syndromic and nonsyndromic congenital heart defects identified by exome sequencing.
Sifrim A.; Hitz M.P.; Wilsdon A.; Breckpot J.; Turki S.H.; Thienpont B.; McRae J.; Fitzgerald T.W.; Singh T.; Swaminathan G.J.; Prigmore E.; Rajan D.; Abdul-Khaliq H.; Banka S.; Bauer U.M.; Bentham J.; Berger F.; Bhattacharya S.; Bu'Lock F.; Canham N.; Colgiu I.G.; Cosgrove C.; Cox H.; Daehnert I.; Daly A.; Danesh J.; Fryer A.; Gewillig M.; Hobson E.; Hoff K.; Homfray T.; Kahlert A.K.; Ketley A.; Kramer H.H.; Lachlan K.; Lampe A.K.; Louw J.J.; Manickara A.K.; Manase D.; McCarthy K.P.; Metcalfe K.; Moore C.; Newbury-Ecob R.; Omer S.O.; Ouwehand W.H.; Park S.M.; Parker M.J.; Pickardt T.; Pollard M.O.; Robert L.; Roberts D.J.; Sambrook J.; Setchfield K.; Stiller B.; Thornborough C.; Toka O.; Watkins H.; Williams D.; Wright M.; Mital S.; Daubeney P.E.; Keavney B.; Goodship J.; Abu-Sulaiman R.M.; Klaassen S.; Wright C.F.; Firth H.V.; Barrett J.C.; Devriendt K.; FitzPatrick D.R.; Brook J.D.; Hurles M.E.;
Nat. Genet. 48:1060-1065(2016)
Cited for: VARIANTS SIHIWES TYR-851; HIS-1068 AND ILE-1608; INVOLVEMENT IN SIHIWES;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.